Navigation Links
St. John's wort collection mined for its medicinal value
Date:3/30/2010

This press release is available in Spanish.

A unique collection of St. John's wort (Hypericum) curated by Agricultural Research Service (ARS) scientists in Ames, Iowa, is providing university collaborators with genetically diverse, well-documented sources of this herb to use in studies examining its medicinal potential.

In collaboration with Mark Widrlechner, a horticulturist with the ARS crop genebank at the North Central Regional Plant Introduction Station in Ames, scientists from the Center for Research on Botanical Dietary Supplements (CRBDS) are screening 180 germplasm accessions of St. John's wort for biologically active compounds. Some may be worth evaluating further in clinical trials for their potential to combat viral infections, reduce inflammation or improve digestive health.

Established in 1948, the ARS Ames crop genebank curates more than 50,000 accessions of ornamental plants, maize, oilseeds, vegetables and other crops, and provides them to researchers for many applications. Accessions with medicinal or nutraceutical value include Echinacea (purple coneflower), Hypericum, Prunella (self-heal) and Actaea racemosa (black cohosh). ARS horticulturist Luping Qu curates the collection and Widrlechner coordinates its use for research at CRBDS, one of six Botanical Research Centers funded by the National Institutes of Health from 2005-2010.

The Hypericum collection at Ames was started in the 1990s and today encompasses about 60 species collected from around the world. This diversity has enabled investigations of genetic, environmental and developmental factors affecting the quantity and quality of bioactive compounds, as well as their modes of action.

Of particular interest is how these compounds interact, and whether those interactions are critical to human health benefits. In a recent issue of Pharmaceutical Biology, researchers noted that combinations of four compounds from St. John's wort (amentoflavone, chlorogenic acid, pseudohypericin and quercetin) were more effective at reducing inflammation in mouse macrophage assays than when each was used alone.


'/>"/>

Contact: Jan Suszkiw
Jan.Suszkiw@ars.usda.gov
301-504-1630
United States Department of Agriculture-Research, Education, and Economics
Source:Eurekalert

Related medicine news :

1. Johns Hopkins Health System Acquires Imorgon Ultrasound PACS Product
2. SC Johnson and Bill & Melinda Gates Foundation Unite to Combat Malaria
3. Johns Hopkins Launches “Energy Policy and Climate” Master's Degree
4. Robert Wood Johnson Foundation Launches New Scholars, Fellows & Leadership Programs Web Site
5. Johnson & Johnson to Participate in RBC Capital Markets Health Care Conference
6. AADR awards the 2010 Jack Hein Public Service Award to David C. Johnsen
7. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
8. Longtime Quality Assurance Executive Randy Johnson Joins White Pine Systems as Vice President of Product Services
9. Protecting patients: Study shows that Johns Hopkins flu vaccination rates twice national average
10. Jimmy Johnson Will Step Into Role as Honorary Crew Chief for ExtenZe Racing at Daytona
11. PJ Johnson Joins StatCom as Enterprise VP, Southeast Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... ... wear distributors and International relief organizations across the globe to provide effective protection ... lifestyle and work wear collections via insectshield.com . In the wake of ...
(Date:4/23/2017)... ... 2017 , ... Altura Communication Solutions, a nationwide provider of ... and SMB specialization. Altura is now qualified to sell, install and support ... Certification, Altura fulfilled the training and exam requirements for the Cisco Small Medium ...
(Date:4/22/2017)... ... April 22, 2017 , ... Brian Emmer ... President of Sales and Business Development at OAKWORKS, Inc. Mr. Emmer is ... development, and strategic planning for the company. Recognized industry-wide as a healthcare ...
(Date:4/21/2017)... ... April 21, 2017 , ... The staff at Palm Beach Face is proud to announce that ... 2017 London Marathon. Set to take place on April 23rd, the London Marathon has a ... will run as part of team EMPOWER, raising money for the international charity, Smile Train. ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Brady ... announced that its B-595 and B-7569 vinyl label materials received ... and warning labels are tested to remain intact and legible, for use on chemical ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... 20, 2017 Research and Markets has announced ... Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex ... ... technologies will rise from USD 20 Billion in 2015 to around ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ...
(Date:4/20/2017)... April 20, 2017 Eyevensys, a ... first non-viral gene expression technology that enables the safe, ... to address a wide range of ophthalmic diseases, announces ... Healthcare products Regulatory Agency (MHRA) to advance its technology ... ...
Breaking Medicine Technology: